↓ Skip to main content

American Association for Cancer Research

Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast CancerMHC-II Is an Immunotherapy Biomarker in Early Breast…

Overview of attention for article published in Clinical Cancer Research, July 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
22 news outlets
twitter
27 X users
facebook
1 Facebook page

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
43 Mendeley